PBH

Prestige Consmr Healthcare Inc

80.28

0.48+0.60%

After Hours: 80.70 +0.42 +0.52%19:42 04/17 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE79.66/79.80

TODAY RANGE79.66-80.94

VOL293.03K

MARKET CAP3.98B

52 WEEK RANGE62.35-90.04

AVG VOL (3M)368.57K

% TURNOVER0.59%

TURNOVER--

P/E (TTM)18.81

% RANGE1.48%

EPS(TTM)4.268

P/E(FORWARD)17.84

P/B2.225

BVPS36.07

DIVIDEND--

P/S3.554

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP3.92B

SHARES OUTSTANDING49.54M

NEXT EARNINGS--

FREE FLOAT48.86M

LOT SIZE1

EX-DIV DATE--

News

Press Releases

Financial Reports

Profile

TipRanks·04/03 11:25
Elf Beauty, Helen of Troy exposed to China tariffs, says Canaccord
Seeking Alpha·03/31 20:03
Impax Small Cap Fund Q4 2024 Commentary
NASDAQ·03/27 13:07
Prestige Consumer Gains 17.1% in a Year: What's Driving the Stock?
NASDAQ·03/25 12:11
Should You Consider Retaining PBH Stock in Your Portfolio Now?
Dow Jones·03/21 17:43
Correction to Premium Brands Holdings Rating
Dow Jones·03/21 16:46
Prestige Consumer Hlthcr Is Maintained at Sector Perform by RBC Capital
Dow Jones·03/21 16:46
Prestige Consumer Hlthcr Price Target Raised to $97.00/Share From $96.00 by RBC Capital
TipRanks·03/06 02:16
Top Executive Sells Thousands of Prestige Consumer Healthcare Shares!
TipRanks·03/03 11:19
Prestige Consumer Healthcare: Undervalued Growth Potential with Strong Financial Performance and Shareholder Return Prospects
NASDAQ·02/17 16:40
PBH or BSX: Which Is the Better Value Stock Right Now?
TipRanks·02/14 02:04
Prestige EVP Executes Major Stock Sale!
Dow Jones·02/13 17:03
Prestige Consumer Hlthcr Is Maintained at Outperform by Oppenheimer
Dow Jones·02/13 17:03
Prestige Consumer Hlthcr Price Target Raised to $93.00/Share From $87.00 by Oppenheimer
TipRanks·02/13 12:35
Prestige Consumer price target raised to $93 from $87 at Oppenheimer
TipRanks·02/10 13:15
D.A. Davidson Sticks to Their Buy Rating for Prestige Consumer Healthcare (PBH)

Same Industry

Name/Symbol

Change%

Price

Prestige Consmr Healthcare Inc

PBH

+0.60%

80.28

McKesson

MCK

+0.34%

697.08

Biogen Inc

BIIB

+2.88%

118.61

Amgen Inc

AMGN

-1.89%

277.29

Shire

SHPG

179.20

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

-22.12%

0.0250

Celgene

CELG

108.24

Lilly Eli & Co

LLY

+14.30%

839.96

Therapeuticsmd Inc

TXMD

+2.02%

1.01

Johnson & Johnson

JNJ

+2.31%

157.47

Abbvie Inc

ABBV

+0.76%

172.99

Zoetis Inc

ZTS

+1.30%

148.67

Gilead Sciences Inc

GILD

-0.32%

104.54

Novo-Nordisk A/S

NVO

-7.63%

58.08

Bristol-Myers Squibb Co

BMY

-0.26%

49.23

Pfizer

PFE

+0.45%

22.14

Alexion Pharms

ALXN

+1.70%

182.50

Sanofi FR

SNY

+0.67%

50.90

Sanofi FR

GCVRZ

0.00%

0.8711

Novartis

NVS

+1.17%

110.86

Dr Reddys Labs

RDY

+1.71%

13.67

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.